GI MD at the First Affiliated Hospital of Sun Yat-sen University, China;Post-doctoral fellow, conducting IBD-related fibrosis research at the Cleveland Clinic
@IBD_FloMD Thanks all the coauthors’ contributions to this paper, especially the nice idea and many supports from Dr Rieder. We are now looking forward to a novel anti-fibrotic therapy for IBD in the near future.
Congratulations to @sinan_lin for this comprehensive work 🔬 Development of Anti-fibrotic Therapy in Stricturing Crohn's Disease: Lessons from Randomized Trials in Other Fibrotic Diseases | Physiological Reviews https://t.co/iVuVWF9YWq Read on 👇🏾👇🏿👇🏻
@IBD_FloMD My honor to join our IBD fibrosis team as a “naive” physician without any lab experience in the last three years. I really appreciate the guidance from Dr. Rieder and Dr. Fiocchi, and all the support from our team. Will always remember the days I spent in Cleveland.
With safety, perseverance, and the will to fight the #CoronaWar, the #RiederLab will continue to be productive while maintaining safety. Thank you to @IBD_FloMD for your amazing understanding and flexibility during this time. @JiannanliMDPhD@IBD_Sir @pranab_IBD @JChandra_IBD